logo

New Drugs Approved In January

Balcoltra
Balcoltra

Oral contraceptive Balcoltra was granted FDA approval on January 9, 2018 for pregnancy prevention.

Developed by Avion Pharmaceuticals, LLC, Balcoltra combines 0.1 mg levonorgestrel, 20 mcg ethinyl estradiol tablets and ferrous bisglycinate tablets 36.5 mg.

Avion expects to commercially launch this new oral contraceptive to the prescribing community in Spring 2018.

Share